William J John

William J John

UNVERIFIED PROFILE

Are you William J John?   Register this Author

Register author
William J John

William J John

Publications by authors named "William J John"

Are you William J John?   Register this Author

17Publications

487Reads

47Profile Views

Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and Japan.

Clin Lung Cancer 2017 11 26;18(6):607-614. Epub 2017 Apr 26.

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.04.011DOI Listing
November 2017

Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study.

J Thorac Oncol 2014 Jul;9(7):991-7

*Division of Medical Oncology, S. Giuseppe Moscati Hospital, Avellino, Italy; †Department of Lung Diseases, San Camillo Hospital, Rome, Italy; ‡Internistische Onkologie der Thoraxtumoren, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany; §Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; ‖Centre Catherine De Sienne, Nantes, France; ¶Christie Hospital NHS Foundation Trust, Manchester, England; #CHR La Citadelle, Liege, Belgium; **Centre Hospitalier Regional Universitaire de Montpellier, Montpellier, France; ††Eli Lilly and Company, Indianapolis, IN; ‡‡Eli Lilly and Company, Madrid, Spain; §§Eli Lilly and Company, Neuilly-sur-Seine Cedex, France; ‖‖Eli Lilly and Company, Houten, The Netherlands; and ¶¶University Hospital, Virgen del Rocio, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000207DOI Listing
July 2014

PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.

J Clin Oncol 2013 Dec 21;31(34):4349-57. Epub 2013 Oct 21.

Jyoti D. Patel, Northwestern University; Philip Bonomi, Rush University Medical Center, Chicago, IL; Mark A. Socinski, University of Pittsburgh, Pittsburgh, PA; Edward B. Garon, University of California at Los Angeles, Los Angeles, CA; Craig H. Reynolds, US Oncology Research, Ocala, FL; David R. Spigel, Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN; Mark R. Olsen, Tulsa Cancer Institute, Tulsa, OK; Robert C. Hermann, Northwest Georgia Oncology Centers, Marietta, GA; Robert M. Jotte, Rocky Mountain Cancer Centers, Denver, CO; Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR; Donald A. Richards, US Oncology Research, Tyler, TX; Susan C. Guba, Jingyi Liu, Bente Frimodt-Moller, and William J. John, Eli Lilly, Indianapolis, IN; Coleman K. Obasaju and Eduardo J. Pennella, Lilly USA, Indianapolis, IN; and Ramaswamy Govindan, Washington University School of Medicine, St. Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.9626DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881367PMC
December 2013

The emerging role of antifolates in the treatment of malignant pleural mesothelioma.

Semin Oncol 2002 Feb;29(1):77-81

Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
February 2002